Below is a brief excerpt from a complimentary research note provided by Hedgeye, an investment research and online financial media company, by cannabis analysts Howard Penney and Daniel Biolsi.
As Penney and Biolsi note, the road may be a long one for the nascent cannabis industry, but recent developments are showing promise in bringing an end to prohibition. The paper considers the comments made by the Wine and Spirits Wholesalers of America on the topic, as well as providing some examples of plans currently under consideration regarding regulation.
Takeaway: The Wine and Spirits Wholesalers of America’s plan is a clear sign we are getting closer to the end of prohibition!
Guess how the Wine and Spirits Wholesalers of America want to regulate the cannabis industry?
A report by the alcohol industry association says, "One of the most remarkable aspects of this system is its adaptability.
The underlying regulations in place today are largely unchanged from nearly a century ago. Yet, innovation abounds — in the form of new products, packaging, retail business models, home delivery, and more."
As a reminder, the alcohol industry has a vested interest in the industry. Constellation Brands [STZ], AB InBev [ABI], and Molson Coors Beverage Company [TAP] have made investments in the cannabis industry.
Those companies are part of a policy coalition launched last week to influence the "how" of federal cannabis regulations. The report outlines four principles of alcohol regulation that it argues would create a good framework for the cannabis industry:
- A federal permitting system for producers, importers, testing facilities, and distributors
- A system for approving and regulating products
- Establishing federal excise taxes
- Creating measures to ensure public safety and reduce intoxicated driving
- The industry would be regulated by the Alcohol and Tobacco Tax and Trade Bureau.
The alcohol model is already under consideration, with Senator Ron Wyden's (D-Ore.) Marijuana Revenue and Regulation Act (introduced in 2019), proposed transferring jurisdiction over cannabis from the Drug Enforcement Administration to the Alcohol and Tobacco Tax and Trade Bureau, which we assume is a de-scheduling of the drug.
That bill also adds "marijuana" to several bills that address liquor and alcohol regulation, such as the Wilson Act, which allows states to continue to prohibit alcohol.
Some specifics of the plan:
- The proposed regulations would require separate licenses for producing and distributing cannabis but would not prohibit companies from holding both. Producers could distribute cannabis within their state without a distribution license — which would only be required for interstate commerce.
- Importing cannabis would require a separate permit, as would operating a cannabis testing facility. States, not the federal government, would regulate retail licenses.
- Recommends that anyone convicted of a non-violent cannabis-related offense should still be eligible for these permits.
- Suggests that cannabis labels require the product name, THC potency, producer information, a health warning, and a country of origin for imports. It also suggests developing national "units of sale" based on milligrams of THC per serving.
- "Beverage alcohol uses 'standards of fill,' which specify the volumes of alcohol that may be sold," the report states. "A similar approach could be developed for cannabis."
- The plan doesn't include the regulation of hemp or CBD products with less than 0.3% THC.
- Proposes taxing cannabis when it leaves the producer or importer for sale — a similar model to alcohol. It also suggests a tax rate based on THC potency, much like alcohol — which has a higher tax rate for stronger beverages.
Like the issues that have slowed legalisation in New York, the data on impaired driving is spotty.
The Wine and Spirits Wholesalers of America's plan suggests that the National Highway Traffic Association Safety Administration work with law enforcement and other federal agencies to research tests to determine impairment from marijuana and develop protocols for training officers to recognise drug impairment.
This article is an excerpt from a research note written by cannabis analysts Howard Penney and Daniel Biolsi, and was originally published by Hedgeye. For more information on where to access the full report, see here.
Disclaimer Past performance is not a reliable indicator of future results.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.
The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.
CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.
*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.